Your blood panel shows three interconnected patterns:
Together, these suggest early metabolic-associated hepatic stress with a nutritional component that may be contributing to liver inflammation.
The elevated ALT level suggests early hepatic cell stress. In the context of normal glucose and bilirubin, this pattern is most consistent with early metabolic-associated hepatic stress rather than acute hepatitis.
Persistent ALT elevation at this level, especially when combined with low Vitamin D, may increase long-term risk for progressive liver disease if left unaddressed.
The Vitamin D level of 28 ng/mL falls below optimal range and contributes to immune dysfunction and may exacerbate hepatic inflammation. Despite elevated ALT, glucose remains normal, suggesting preserved insulin sensitivity at this stage.
Vitamin D deficiency is independently associated with increased hepatic inflammation and fibrosis progression. Repletion may improve both immune function and hepatic outcomes.
The combination of elevated hepatic enzymes and low Vitamin D suggests a state of chronic low-grade inflammation. Vitamin D modulates immune responses, and its deficiency can lead to dysregulated inflammatory pathways that may contribute to hepatic stress.
Chronic inflammation, even at subclinical levels, contributes to long-term tissue damage. Addressing the nutritional component may help break this inflammatory cycle.
Begin Vitamin D3 supplementation 3000 IU daily with your largest meal containing fat. Recheck level in 10 weeks to assess response.
Implement Mediterranean diet pattern, engage in regular moderate exercise (150 minutes/week), and abstain from alcohol for 8-12 weeks while monitoring hepatic enzymes.
Repeat comprehensive metabolic panel in 10-12 weeks to evaluate response to interventions and determine if additional testing is warranted.
Discuss with your physician whether fibrosis markers (like PRO-C3 or hyaluronic acid) or specialist referral would be beneficial given the persistent ALT elevation.